Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum (Q42466651)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Maeda T

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Kannari K

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Suda T

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Matsunaga M

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

817

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

185-191

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Dendritic release of dopamine in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Where isl-DOPA decar☐ylated in the striatum after 6-hydroxydopamine nigrotomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Self-inhibition by Dopaminergic Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Carrier-mediated release of neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Nonaminergic striatal neurons convert exogenous l-dopa to dopamine in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Dopamine formation from L-dopa administered exogenously is independent of dopaminergic neuronal activity: studies with in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Decarboxylation of Exogenous l-3,4-Dihydroxyphenylalanine in Rat Striatum as Studied by In Vivo Voltammetry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

L-dopa in Parkinsonism. A possible mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Combined bromocriptine-levodopa therapy early in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901248-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(98)01248-7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42466651&oldid=2035448542"